2019 Urticaria Pigmentosa (Mastocytoma) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 56 pages | ID: 28BEB214EAEEN
VPAResearch

Abstracts

The global clinical trial report- “2019 Urticaria Pigmentosa (Mastocytoma) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Urticaria Pigmentosa (Mastocytoma). It presents in-depth analysis of Urticaria Pigmentosa (Mastocytoma) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Urticaria Pigmentosa (Mastocytoma).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Urticaria Pigmentosa (Mastocytoma) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Urticaria Pigmentosa (Mastocytoma)

The research work is prepared through extensive and continuous research on Urticaria Pigmentosa (Mastocytoma) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Urticaria Pigmentosa (Mastocytoma) patients are identified
• The report includes panorama of Urticaria Pigmentosa (Mastocytoma) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Urticaria Pigmentosa (Mastocytoma) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Urticaria Pigmentosa (Mastocytoma) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Urticaria Pigmentosa (Mastocytoma) Clinical Trials by Region
  2.2.2 Average Enrollment of Urticaria Pigmentosa (Mastocytoma) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Urticaria Pigmentosa (Mastocytoma) Treatment, 2019

3. REGION WISE URTICARIA PIGMENTOSA (MASTOCYTOMA) CLINICAL TRIALS

3.1 Asia Pacific Urticaria Pigmentosa (Mastocytoma) Clinical Trials by Country
3.2 Europe Urticaria Pigmentosa (Mastocytoma) Clinical Trials by Country
3.3 North America Urticaria Pigmentosa (Mastocytoma) Clinical Trials by Country
3.4 Middle East and Africa Urticaria Pigmentosa (Mastocytoma) Clinical Trials by Country
3.5 South and Central America Urticaria Pigmentosa (Mastocytoma) Clinical Trials by Country

4. URTICARIA PIGMENTOSA (MASTOCYTOMA) CLINICAL TRIAL TRENDS

4.1 Start Year wise Urticaria Pigmentosa (Mastocytoma) Clinical Trials
4.2 Phase wise Urticaria Pigmentosa (Mastocytoma) Clinical Trials
4.3 Trial Status wise Urticaria Pigmentosa (Mastocytoma) Clinical Trials
4.4 Trial Type wise Urticaria Pigmentosa (Mastocytoma) Clinical Trials

5. URTICARIA PIGMENTOSA (MASTOCYTOMA) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Urticaria Pigmentosa (Mastocytoma) Trials by Year
5.2 Average Enrollment in Urticaria Pigmentosa (Mastocytoma) Trials by Phase
5.3 Average Enrollment in Urticaria Pigmentosa (Mastocytoma) Trials by Status
5.4 Average Enrollment in Urticaria Pigmentosa (Mastocytoma) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN URTICARIA PIGMENTOSA (MASTOCYTOMA) CLINICAL TRIALS

6.1 Urticaria Pigmentosa (Mastocytoma) Trials by Sponsor Type
6.2 Urticaria Pigmentosa (Mastocytoma) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Urticaria Pigmentosa (Mastocytoma) Trials- Phase
7.2 Urticaria Pigmentosa (Mastocytoma) Trials- Phase
7.3 Urticaria Pigmentosa (Mastocytoma) Trials- Phase
7.4 Urticaria Pigmentosa (Mastocytoma) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Urticaria Pigmentosa (Mastocytoma) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Urticaria Pigmentosa (Mastocytoma) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Urticaria Pigmentosa (Mastocytoma) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Urticaria Pigmentosa (Mastocytoma) Clinical Trials and Enrolment
Figure 7: North America – Country wise Urticaria Pigmentosa (Mastocytoma) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Urticaria Pigmentosa (Mastocytoma) Clinical Trials and Enrolment
Figure 9: Urticaria Pigmentosa (Mastocytoma) Clinical Trials by Phase
Figure 10: Urticaria Pigmentosa (Mastocytoma) Clinical Trials by Trial Status
Figure 11: Urticaria Pigmentosa (Mastocytoma) Clinical Trials by Type
Figure 12: Urticaria Pigmentosa (Mastocytoma) Clinical Trials by Sponsor Type
Figure 13: Urticaria Pigmentosa (Mastocytoma) Clinical Trials by Leading Sponsors
Figure 14: Urticaria Pigmentosa (Mastocytoma) Average Enrollment by Phase
Figure 15: Urticaria Pigmentosa (Mastocytoma) Average Enrollment by Trial Status
Figure 16: Urticaria Pigmentosa (Mastocytoma) Average Enrollment by Type
Figure 17: Urticaria Pigmentosa (Mastocytoma)- Average Enrolment by Type of Sponsors
Figure 18: Urticaria Pigmentosa (Mastocytoma)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Urticaria Pigmentosa (Mastocytoma) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Urticaria Pigmentosa (Mastocytoma) Clinical Trials and Enrolment
Table 5: Europe – Country wise Urticaria Pigmentosa (Mastocytoma) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Urticaria Pigmentosa (Mastocytoma) Clinical Trials and Enrolment
Table 7: North America – Country wise Urticaria Pigmentosa (Mastocytoma) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Urticaria Pigmentosa (Mastocytoma) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Urticaria Pigmentosa (Mastocytoma) Average Enrollment by Phase
Table 15: Urticaria Pigmentosa (Mastocytoma) Average Enrollment by Trial Status
Table 16: Urticaria Pigmentosa (Mastocytoma) Average Enrollment by Type
Table 17: Urticaria Pigmentosa (Mastocytoma)- Average Enrolment by Type of Sponsors
Table 18: Urticaria Pigmentosa (Mastocytoma)- Enrolment by Leading Sponsors